APP and Parkinson disease: For example, amyloid precursor protein fragments (APP) or tau phosphorylated at Thr181 are established biomarkers for Alzheimer’s disease, and phosphorylated tau or α-synuclein are relevant for Parkinson’s disease (Saman et al., 2012; Yang et al., 2015).